INTRODUCTION
Chronic mesenteric ischemia (CMI) is an uncommon disorder caused by atherosclerotic occlusion or stenosis of the mesenteric arteries (1) . CMI symptoms classically develop when there is significant stenosis or occlusion of at least two of the three mesenteric arteries (2) . Endovascular therapy is increasingly accepted as the first line of therapy for CMI due to its lower morbidity and mortality rate and similar outcome compared with open surgery (1) (2) (3) (4) (5) .
In celiacomesenteric trunk (CMT), the celiac artery (CA) and superior mesenteric artery (SMA) arise from a common origin (6) . Patients with CMT variation develop CMI when atheromatous disease causes occlusion of both the proximal CA and SMA at their common trunk. We report a case of CMT variant with severe stenosis of the trunk ostium and a totally occluded SMA that was successfully treated with overlapping CA and SMA stents in the trunk portion.
CASE REPORT
A 73-year-old woman with a 3-month history of postprandial abdominal pain and weight loss was referred to our department for evaluation. Contrast-enhanced computed tomography (CT) scan revealed a common trunk of the CA and SMA, with total SMA occlusion. There were no signs of bowel ischemia, such as bowel wall thickening or abnormal contrast enhancement.
A 5-Fr RH catheter (Cook, Bloomington, IN, USA) was inserted in the right common femoral artery. Angiography confirmed CMT with significant stenosis of the trunk and complete occlusion of the proximal portion of the SMA (Fig. 1A) . The distal portion of the SMA showed faint retrograde filling via the pancreaticoduodenal arcade. We first attempted to cross the obstructed SMA through the stenotic trunk, using a 5-Fr Cobra A 73-year-old woman was presented with a 3-month history of postprandial abdominal pain and weight loss. The patient had an anatomic variant of celiacomesenteric trunk (CMT), with complete occlusion of the superior mesenteric artery (SMA) and significant stenosis of the CMT ostium, resulting in chronic mesenteric ischemia. After several unsuccessful attempts at revascularization of the SMA, celiac artery stenting was performed, followed by SMA stent placement through the previously placed stent mesh into the occlusion site. The patient's symptoms completely resolved after treatment. (Fig. 1B) . The patient' s symptoms were immediately resolved after the procedure, and she was discharged 2 days later.
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catheter (Cook, Bloomington, IN, USA) and 0.035-inch guide wire (Radifocus; Terumo, Tokyo, Japan). However, the catheter persistently slid into the connected celiac artery because the completely occluded SMA had a downward course and the ostium of the CMT had severely stenosed and could not negotiate the SMA. After several unsuccessful attempts to negotiate the SMA, we decided to first treat the CMT ostium stenosis. A 6-Fr renal guiding catheter (Cordis, Miami, FL, USA) was advanced over the wire so that the tip was placed proximal to the ostium of (Fig. 1E ). There were no complications, and the patient's symptoms were immediately resolved.
Six months later, the patient had no clinical symptoms, and she regained her weight.
DISCUSSION
The cause of CMI is progressive atherosclerotic stenosis or occlusion of one or more mesenteric arteries (1). However, clinical manifestations of CMI are rare because atheromatous disease usually involves the proximal portion of the mesenteric arteries, allowing collateral blood flow to the intestine (2). Treatment of stenosis or occlusion of mesenteric vessels is indicated for intestinal ischemia-related symptoms, such as postprandial pain, weight loss, nausea, and diarrhea (3). The aims of treatment are to improve symptoms and prevent ischemic injury to the bowel.
Historically, CMI has been treated by surgical revascularization.
However, surgery has a 15-47% morbidity rate and a 0-17% mortality rate, higher than that of endovascular treatment (1) . The overall outcome of the endovascular treatment of CMI compares favorably with surgery (7). Although endovascular treatment has
